What Mr. Restall means is that the great explorer is still at the center of a swarm of unresolved polemics. Historians have not, in other words, laid him to unanimous rest. In fact, to describe ...
COLUMBUS, Ohio (WCMH) — For friends and families seeking a festive dining experience during the holidays, the Columbus area offers a variety of options. From upscale steakhouses to casual spots, these ...
COLUMBUS, Ohio — United States Immigration and Customs Enforcement (ICE) released a statement on Friday regarding the agency's recent operations in Columbus. The statement says that the enforcement ...
Columbus is likely to hit a milestone in violent crime prevention it hasn't seen in about a decade: keeping the number of homicides in the city under 100. The Mothers of Murdered Columbus Children, or ...
If you think there's been a lot of snow in Columbus, you're not just seeing things. The city has already posted its snowiest December since 2013 with more than half the month to go. So far, Columbus ...
COLUMBUS, Ohio (WCMH) – It appears that the Columbus Promise program could end up being a broken promise. Columbus Promise is a joint initiative for the City of Columbus and Columbus State Community ...
If you’re looking for something to entertain the whole family for this holiday season, the Columbus Ledger-Enquirer is here for you. Whether you want to spend money or enjoy for free, here is a ...
COLUMBUS, Ohio — The Columbus Crew’s downtown stadium will have a new name starting with the 2026 season under an expanded partnership with Scotts Miracle-Gro Company announced today.
Please provide your email address to receive an email when new articles are posted on . NEW YORK — Congenital cytomegalovirus is the most common nongenetic cause of hearing loss in childhood, yet many ...
CAMBRIDGE, MA / ACCESS Newswire / October 22, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced topline results from a Phase 3 pivotal trial evaluating the efficacy of mRNA-1647, the Company’s ...
Moderna, Inc. (NASDAQ:MRNA) revealed topline results on Wednesday from a Phase 3 trial evaluating the efficacy of mRNA-1647, the company’s investigational cytomegalovirus (CMV) vaccine. CMV is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results